{
    "2019-01-29": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Cramer's lightning round: AbbVie needs to make an acquisitionâ€”it might just save its stock",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "acquisition",
                        "stock"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "gains",
                        "market dips"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "10 Value Stocks to Buy for 2019 and Beyond",
                "features": {
                    "keywords": [
                        "value stocks",
                        "buy",
                        "2019"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y",
                "features": {
                    "keywords": [
                        "Biogen",
                        "earnings",
                        "beat",
                        "revenues up"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "AbbVie's Imbruvica Combo Gets FDA Nod in First-Line Setting",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Imbruvica",
                        "FDA",
                        "nod"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "3 Top Dividend Stocks to Buy Right Now",
                "features": {
                    "keywords": [
                        "dividend",
                        "stocks",
                        "buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Jacksonville's increasing use of LNG as a transportation fuel",
                "features": {
                    "keywords": [
                        "LNG",
                        "transportation",
                        "fuel"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Imbruvica Is Key Growth Driver for AbbVie in Fiscal 2019",
                "features": {
                    "keywords": [
                        "Imbruvica",
                        "growth driver",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Health Care Sector Update for 01/29/2019: ARAY, TRVN, ABBV, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "health care",
                        "sector update",
                        "ARAY",
                        "TRVN",
                        "ABBV",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Why Humira Revenues in International Markets Are Expected to Fall",
                "features": {
                    "keywords": [
                        "Humira",
                        "revenues",
                        "fall",
                        "international markets"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "AbbVie Missed EPS Estimates in Q4 2018",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "missed",
                        "EPS",
                        "estimates"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",
                "features": {
                    "keywords": [
                        "biotech",
                        "pharma earnings",
                        "Kiniksa",
                        "offering",
                        "FDA",
                        "Aquestive"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}